The immunophenotypic profile-predominance of CD20+ and PAX 5+ B cells with BCL6 expression and BCL2 negativity is characteristic of reactive nodal or cutaneous lymphoid hyperplasia, as opposed to most B-cell lymphomas [7,8]. This evidence concerns the gene BCL6 and B-cell non-Hodgkin lymphoma.